FIELD: veterinary science; pharmaceutics.
SUBSTANCE: invention relates to veterinary pharmacy, in particular to preparations for the treatment and prevention of cardiac pathologies in animals and can be used in veterinary science and animal breeding for the treatment and prevention of cardiovascular diseases in animals. Disclosed is an antioxidant preparation for the treatment and prevention of cardiac pathologies in animals, comprising 3-oxypyridine derivative, in form of methylethylpyridinol hydrochloride, meldonium dihydrate, inosine, polyvinylpyrrolidone and water for injections, at the following ratio of components, wt.%: methylethylpyridinol hydrochloride – 0.8–1.2; inosine – 0.8–1.2; meldonium dihydrate – 1.5–2.5; polyvinylpyrrolidone – 2.5–4.5; water for injections – balance.
EFFECT: preparation provides evident cardioprotective, antioxidant and cardiotrophic action, has low toxicity, provides high effectiveness of prevention and treatment of cardiovascular diseases in animals, ease of administration and dosage.
1 cl, 7 dwg, 7 ex
Title | Year | Author | Number |
---|---|---|---|
ANTIOXIDANT PREPARATION FOR TREATING AND PREVENTING NEUROLOGICAL PATHOLOGIES IN ANIMALS | 2023 |
|
RU2813928C1 |
METHOD FOR CATARACT TREATMENT AND EYE DROPS FOR IMPLEMENTATION THEREOF | 2016 |
|
RU2662364C2 |
AGENT FOR PREVENTING PROGRESSION OF APOPTOTIC AND ARRESTING NECROTIC ALTERATIONS IN BODY TISSUE | 2005 |
|
RU2311180C2 |
PREPARATION FOR PREVENTING AND TREATING INFLAMMATORY PROCESSES IN ANIMALS | 2019 |
|
RU2725773C1 |
STABLE LIQUID PHARMACEUTICAL COMPOSITION OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE DISUCCINATE COMPLEX, HAVING ANTIHYPOXIC, ANTIOXIDANT AND ADAPTOGENIC ACTION | 2013 |
|
RU2527347C1 |
ANTIOXIDANT ANTI-INFLAMMATORY PREPARATION FOR ANIMALS | 2018 |
|
RU2686462C1 |
COMBINATION DRUG FOR PARENTERAL ADMINISTRATION CONTAINING METHYLETHYL PYRIDINOL HYDROCHLORIDE OR SUCCINATE AND RIBOFLAVIN | 2014 |
|
RU2566725C1 |
ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
PREPARATION FOR NORMALISATION OF LIPID PEROXIDATION PROCESSES IN ANIMALS | 2013 |
|
RU2538666C2 |
AGENT FOR TREATMENT OF PATIENTS WITH NONSTABLE STENOCARDIA AND ACUTE MYOCARDIAL INFARCTION | 2000 |
|
RU2168993C1 |
Authors
Dates
2024-05-06—Published
2023-11-08—Filed